A phase 3b, open-label, single-arm, multicenter, expanded-access study of the safety and clinical outcomes of StrataGraft® treatment in adults with deep partial-thickness thermal burns
Author:
Holmes IV James H.,
Gibson Angela L.F.,
Short Tracee,
Joe Victor C.,
Litt Jeffrey,
Carson JoshuaORCID,
Carter Jeffrey E.,
Wibbenmeyer Lucy,
Hahn Helen,
Smiell Janice M.,
Rutan Randi,
Wu Richard,
Shupp Jeffrey W.
Reference17 articles.
1. Browning J.A., Cindass R. Burn Debridement, Grafting, and Reconstruction. StatPearls. Treasure Island (FL); 2022.
2. Treating pain on skin graft donor sites: review and clinical recommendations;Sinha;J Trauma Acute Care Surg,2017
3. Advancements in regenerative strategies through the continuum of burn care;Stone Ii;Front Pharmacol,2018
4. A phase 3, open-label, controlled, randomized, multicenter trial evaluating the efficacy and safety of StrataGraft® construct in patients with deep partial-thickness thermal burns;Gibson;Burns,2021
5. Determining clinically meaningful thresholds for innovative burn care products to reduce autograft: a US burn surgeon Delphi panel;Gibson;Burns,2021